ASCB/EMBO Conference

ASCBINFO ASCBINFO at ASCB.FASEB.ORG
Wed May 3 09:58:53 EST 1995


     CYTOSKELETAL PROTEINS AND NEURODEGENERATIVE DISEASE
     
     The preliminary program for the ASCB/EMBO meeting,
     Cytoskeletal Proteins and Neurodegenerative Disease to
     be held August 5-10, 1995 at Robinson College,
     Cambridge, U.K. will include the following topics and
     speakers:
     
     General Discussion of Kinases and Phosphatases:  Philip
     Cohen, University of Dundee.
     
     General Discussion of Cytoskeletal Proteins:  Ueli
     Aebi, Maurice E. Mller Institute, University of Basel;
     Nicholas Cowan, New York University College of
     Medicine; Craig Garner, University of Alabama,
     Birmingham; Nobutaka Hirokawa, University of Tokyo
     School of Medicine; Ken Kosik,  Harvard Medical School,
     Boston; Ronald Liem, Columbia University College of
     Physicians and Surgeons, New York; Eva-Maria Mandelkow,
     Max Planck Gesellschaft, Hamburg; Andrew Matus,
     Friedrich Miescher Institute, Basel; Ralph A. Nixon,
     McLean Hospital, Belmont, and Jacques Nunez, INSERM,
     Crteil.  
     
     Neurofilament Diseases:  Don Cleveland, Ludwig
     Institute/UCSD, La Jolla; Robert Goldman, Northwestern
     University Medical School, Chicago; Jean-Pierre Julien,
     Montreal General Hospital; Harish Pant, NIH/NINDS,
     Bethesda; Donald Price, Johns Hopkins University School
     of Medicine, Baltimore, and John Trojanowski,
     University of Pennsylvania School of Medicine,
     Philadelphia.  
     
     Pathological Changes in Alzheimer's Diseases:  Heiko
     Braak, University of Frankfurt, and Peter Davies,
     Albert Einstein College of Medicine, New York.  
     
     Tau Protein in Alzheimer's Disease:  Brian Anderton,
     Institute of Psychiatry, London; Thomas Arendt, Paul
     Flechsig Inst fur Hirnforschung, Leipzig; Jesus Avila,
     Universitad Autonoma de Madrid; Lester Binder,
     Northwestern University Medical School, Chicago; Jean-
     Pierre Brion, Universit Libre de Bruxelles; Tony
     Crowther, Medical Research Council, Cambridge, England;
     Michel Goedert, Medical Research Council, Cambridge,
     England; Jrgen Gtz, Institut fr Molekularbiologie,
     Univeristy of Zurich; Masato Hasegawa, University of
     Tokyo; Khalid Iqbal, New York Institute for Basic
     Research, New York; Gail Johnson, University of
     Alabama, Birmingham; Michael Kidd, Queen's Medical
     Centre, Nottingham; Virginia Lee, University of
     Pennsylvania School of Medicine, Philadelphia; Eckhard
     Mandelkow, Max Planck Gesellschaft, Hamburg; Allen
     Roses, Duke University School of Medicine, Durham;
     Eugeen Vanmechelen, Innogenetics, Ghent, and Shu-Hui
     Yen, Albert Einstein College of Medicine, New York.  
     
     Other Neurodegenerative Diseases:  David Armstrong,
     Allegheny-Singer Research Institute, Pittsburgh;
     Valerie Askanas, University of Southern California, Los
     Angeles; Bernardino Ghetti, Indiana University School
     of Medicine, Indianapolis; Alphonse Probst, University
     of Basel, and Maria Grazia Spillantini, Medical
     Research Council, Cambridge, England.
     
     A limited number of platform speakers will be selected
     from submitted abstracts.  Deadline for platform
     consideration is May 15, 1995.  Applicants will be
     accepted on a space available basis after May 15.  For
     additional information and an application form, contact
     Dorothy Doyle, ASCB, 9650 Rockville Pike, Bethesda MD
     20814. Tel: 301-530-7154; Fax: 301-530-7139; e-mail:
     ddoyle at ascb.faseb.org
     
     



More information about the Neur-sci mailing list